Objective To investigate the relationship between change of intestinal mucosal permeability and liver function classification in patients with liver cirrhosis. Methods A total of 96 patients with liver cirrhosis who were treated in Clinical Laboratory, The Sixth People's Hospital of Zhengzhou from November 2020 to April 2022 were selected as an observation group, and were divided into three subgroups, group A, B, and C (35, 43, and 18 cases), according to the Child-Pugh liver function classification. During the same period, 40 healthy controls without liver cirrhosis were selected as a control group. Group A included 25 males and 10 females, aged (55.01±8.71) years; group B included 30 males and 13 females, aged (55.19±8.76) years; group C included 14 males and 4 females, aged (55.34±8.81) years; the control group included 27 males and 13 females, aged (54.52±8.56) years. The fecal sample was collected, the changes of main intestinal flora were determined by bacterial culture, and the intestinal mucosal permeability indexes [D-lactic acid (D-LAC), endotoxin (ETX), and diamine oxidase (DAO)] were determined. Pearson correlation analysis was used to analyze the correlations among intestinal mucosal permeability indexes, Spearman correlation analysis was used to analyze the correlations between intestinal mucosal permeability indexes and Child-Pugh liver function classification, and the receiver operating characteristic curve (ROC) was used to analyze the predictive values of intestinal mucosal permeability indexes. F test and independent-sample t test were used for the measurement data and χ2 test was used for the count data. Results The numbers of enterobacterium [(8.61±0.42) lgCFU/g, (8.95±0.39) lgCFU/g, and (9.22±0.56) lgCFU/g] and enterococcus [(7.75±0.46) lgCFU/g, (8.42±0.87) lgCFU/g, and (9.28±0.63) lgCFU/g] in group A, B, and C were all higher than those in the control group [(8.12±0.68) lgCFU/g and (7.18±0.71) lgCFU/g], and the numbers of Lactobacillus [(9.08±0.63) lgCFU/g, (8.60±0.48) lgCFU/g, and (8.04±0.76) lgCFU/g] and bifidobacterium [(9.15±0.58) lgCFU/g, (8.54±0.61) lgCFU/g, and (7.96±0.82) lgCFU/g] were lower than those in the control group [(9.85±1.01) lgCFU/g and (9.97±0.96) lgCFU/g], with statistically significant differences (all P<0.05). With the increase of Child-Pugh liver function classification, the numbers of enterobacterium and enterococcus showed an upward trend, while the numbers of Lactobacillus and bifidobacterium showed a downward trend, with statistically significant differences (all P<0.05). The levels of D-LAC [(5.83±2.63) mg/L, (8.75±3.27) mg/L, and (10.16±3.58) mg/L], ETX [(10.53±4.36) U/L, (12.67±5.12) U/L, and (23.08±9.37) U/L], and DAO [(34.06±10.36) U/L, (40.12±11.72) U/L, and (43.07±14.20) U/L] in group A, B, and C were higher than those in the control group [(3.92±2.27) mg/L, (3.72±2.51) U/L, and (3.65±1.63) U/L], with statistically significant differences (all P<0.05). The levels of D-LAC and DAO in group B and C were higher than those in group A (all P<0.05), but there were no statistically significant differences between group B and C (both P>0.05). The level of ETX in group C was higher than those in group A and B (both P<0.05), but there was no statistically significant difference between group A and B (P>0.05). Pearson correlation analysis showed that D-LAC was positively correlated with ETX and DAO (r=0.595 and 0.489; both P<0.05), and ETX was positively correlated with DAO (r=0.353, P<0.05). Spearman correlation analysis showed that D-LAC, ETX, and DAO were positively correlated with Child-Pugh liver function classification (r=0.468, 0.470, and 0.236; all P<0.05). ROC analysis showed that D-LAC had the highest diagnostic value in predicting Child-Pugh liver function classification, the area under the curve (AUC) was 0.772, the optimal cut-off value was 6.60 mg/L, and the sensitivity and specificity were 78.69% and 65.71%, respectively. Conclusions The intestinal microecological imbalance caused by intestinal flora disturbance and intestinal mucosal permeability changes in patients with liver cirrhosis can aggravate the disease and is not conducive to the prognosis. Non-invasive, reliable, and practical monitoring on intestinal mucosal permeability indicators helps to provide important guidance for the diagnosis and treatment of patients with liver cirrhosis.